Iqvia Partners with Duke Clinical Research Institute to Enhance Obesity Research
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 10 2026
0mins
Should l Buy IQV?
Iqvia and the Duke Clinical Research Institute announced their new collaboration to enhance the conduct of clinical research in obesity and related cardiometabolic trials. "By combining Iqvia's operational excellence and global reach with DCRI's academic rigor, we are setting a new standard for prospective collaboration between life science service companies and academic research organizations to accelerate clinical trial planning and delivery in obesity and related therapeutic areas," said Jeffrey Spaeder, chief medical and scientific officer, Iqvia. "Uniting our combined clinical strength and complementary capabilities enables us to maximize trial efficiency, accelerate timelines and ultimately bring impactful therapies to patients faster."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IQV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IQV
Wall Street analysts forecast IQV stock price to rise
15 Analyst Rating
12 Buy
3 Hold
0 Sell
Strong Buy
Current: 164.440
Low
215.00
Averages
258.31
High
290.00
Current: 164.440
Low
215.00
Averages
258.31
High
290.00
About IQV
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Worst Performing Large-Cap Stocks Last Week
- Stellantis Loss Warning: Stellantis (NYSE:STLA) plummeted 26.24% this week after the company warned of a full-year net loss, significantly eroding investor confidence and potentially impacting future financing capabilities.
- Gartner Earnings Miss: Gartner (NYSE:IT) fell 25.41% this week following the release of its fourth-quarter financial results and a downward revision of its FY26 guidance, with analysts' pessimistic outlook likely to exert further pressure on the stock.
- Reddit Stock Decline: Reddit (NYSE:RDDT) dropped 23.10% this week as multiple analysts lowered their price forecasts, reflecting market concerns over its profitability and potentially hindering its financing and expansion plans.
- Analyst Downgrades: Several analysts adjusted their price targets downward for these companies, indicating a widespread bearish sentiment regarding their future performance, which may lead investors to reassess their portfolios.
See More
US Stocks Plunge as Tech Sector Leads Decline
- Tech Sector Decline: Qualcomm's (QCOM) forecast of weaker-than-expected Q2 revenue led to an over 8% drop in its stock, triggering a sell-off across the tech sector, with the Nasdaq 100 index hitting a 2.5-month low, indicating waning investor confidence in technology stocks.
- Weak Labor Market Signals: Challenger's report revealed a staggering 117.8% year-over-year increase in job cuts for January, totaling 108,435, the highest for January since 2009, while initial jobless claims rose by 22,000 to 231,000, highlighting vulnerabilities in the US labor market that could hinder economic recovery.
- Bitcoin Plunge: Bitcoin (^BTCUSD) plummeted over 12% to a 1.25-year low, reflecting deepening negative momentum in the cryptocurrency market, with approximately $2 billion flowing out of Bitcoin ETFs in the past month, signaling a decline in investor confidence.
- Earnings Season Impact: Despite 150 S&P 500 companies set to report earnings this week, market focus on economic data intensifies, with S&P 500 earnings expected to grow by 8.4% in Q4, yet overall market sentiment remains suppressed by recent economic weakness.
See More
US Stocks Plunge Sharply, Led by Technology Sector Declines
- Technology Sector Decline: Qualcomm (QCOM) forecasts Q2 revenue between $10.2 billion and $11.0 billion, below the consensus of $11.18 billion, leading to an over 8% drop in its stock and exacerbating the overall decline in the Nasdaq 100 index, heightening market panic.
- Weak Labor Market Signals: Challenger's report shows January job cuts surged 117.8% year-on-year to 108,435, marking the highest level since 2009, indicating fragility in the US labor market and increasing investor concerns about economic outlook.
- Bitcoin Price Crash: Bitcoin (^BTCUSD) is down more than 7% today, hitting a 1.25-year low and falling about 45% from its October record high, reflecting negative sentiment in the cryptocurrency market and a trend of capital outflows.
- Impact of Earnings Season: Despite 150 S&P 500 companies set to report earnings this week and 81% of the 237 companies that have reported exceeding expectations, market concerns over future economic data continue to suppress stock performance, with S&P earnings growth expected to reach 8.4% in Q4.
See More
U.S. Stocks Extend Losses, Led by Technology Sector Declines
- Technology Sector Decline: Qualcomm (QCOM) forecasts Q2 revenue between $10.2 billion and $11.0 billion, below the consensus of $11.18 billion, leading to a more than 9% drop in its stock and triggering a sell-off across the chip sector, exacerbating market anxiety.
- Weak Labor Market Signals: Challenger reports a staggering 117.8% year-over-year increase in job cuts for January, totaling 108,435, the highest since 2009, while initial jobless claims rose by 22,000 to 231,000, indicating a weakening labor market that could impact consumer confidence and spending.
- Fed Policy Implications: Fed Governor Lisa Cook supports the decision to hold interest rates steady, emphasizing the need to maintain credibility after nearly five years of above-target inflation, which may influence future monetary policy directions.
- Bitcoin Market Turmoil: Bitcoin (^BTCUSD) is down over 3% today, hitting a 1.25-year low and falling approximately 45% from its October record high, with about $5 billion pulled from Bitcoin ETFs over the past three months, reflecting waning market confidence in cryptocurrencies.
See More
Analysis of IQV's 52-Week High and Low Points
- Price Range Analysis: IQV's 52-week low is $134.645 and high is $247.045, with the last trade at $185.35, indicating significant price volatility over the past year, reflecting varying market expectations regarding its future performance.
- Technical Analysis Insight: According to data from TechnicalAnalysisChannel.com, IQV's stock price has fallen below its 200-day moving average, which may suggest increased selling pressure in the short term, prompting investors to monitor subsequent market reactions to assess potential risks.
- Market Sentiment Impact: The current price of $185.35, compared to the 52-week high of $247.045, indicates a weakening market confidence in IQV, which could affect investor buying decisions and the company's future financing capabilities.
- Investor Focus: As IQV's stock price approaches its 52-week low, investors may reassess their investment strategies, particularly in the context of increasing market volatility, necessitating close attention to the company's fundamentals and industry dynamics.
See More
IQVIA Reports Strong Q4 but Lowers Full-Year Outlook
- Earnings Performance: IQVIA reported adjusted EPS of $3.42 and revenue of $4.4 billion for Q4 2025, exceeding market expectations by $0.02 and $120 million, respectively, reflecting approximately 10% year-over-year growth; however, shares fell, indicating market concerns about future guidance.
- Segment Growth: The Research & Development Solutions segment contributed $2.3 billion to revenue, while Technology & Analytics Solutions generated $1.8 billion, both showing around 10% year-over-year growth, underscoring the company's robust performance in its core business areas.
- Financial Outlook: Despite a strong 2025, IQVIA projected adjusted EPS of $12.55 to $12.85 for 2026 on revenue of $17.15 billion to $17.35 billion, which is below the consensus estimates of $12.96 and $17.08 billion, reflecting cautious market sentiment regarding future growth.
- Strategic Positioning: CEO Ari Bousbib emphasized that IQVIA's expanded go-to-market strategy, operational discipline, and investments in AI innovations have led to strong growth in both commercial and clinical businesses, positioning the company well for 2026 and beyond.
See More
Worst Performing Large-Cap Stocks Last Week
- Stellantis Loss Warning: Stellantis (NYSE:STLA) plummeted 26.24% this week after the company warned of a full-year net loss, significantly eroding investor confidence and potentially impacting future financing capabilities.
- Gartner Earnings Miss: Gartner (NYSE:IT) fell 25.41% this week following the release of its fourth-quarter financial results and a downward revision of its FY26 guidance, with analysts' pessimistic outlook likely to exert further pressure on the stock.
- Reddit Stock Decline: Reddit (NYSE:RDDT) dropped 23.10% this week as multiple analysts lowered their price forecasts, reflecting market concerns over its profitability and potentially hindering its financing and expansion plans.
- Analyst Downgrades: Several analysts adjusted their price targets downward for these companies, indicating a widespread bearish sentiment regarding their future performance, which may lead investors to reassess their portfolios.
See More
US Stocks Plunge as Tech Sector Leads Decline
- Tech Sector Decline: Qualcomm's (QCOM) forecast of weaker-than-expected Q2 revenue led to an over 8% drop in its stock, triggering a sell-off across the tech sector, with the Nasdaq 100 index hitting a 2.5-month low, indicating waning investor confidence in technology stocks.
- Weak Labor Market Signals: Challenger's report revealed a staggering 117.8% year-over-year increase in job cuts for January, totaling 108,435, the highest for January since 2009, while initial jobless claims rose by 22,000 to 231,000, highlighting vulnerabilities in the US labor market that could hinder economic recovery.
- Bitcoin Plunge: Bitcoin (^BTCUSD) plummeted over 12% to a 1.25-year low, reflecting deepening negative momentum in the cryptocurrency market, with approximately $2 billion flowing out of Bitcoin ETFs in the past month, signaling a decline in investor confidence.
- Earnings Season Impact: Despite 150 S&P 500 companies set to report earnings this week, market focus on economic data intensifies, with S&P 500 earnings expected to grow by 8.4% in Q4, yet overall market sentiment remains suppressed by recent economic weakness.
See More
US Stocks Plunge Sharply, Led by Technology Sector Declines
- Technology Sector Decline: Qualcomm (QCOM) forecasts Q2 revenue between $10.2 billion and $11.0 billion, below the consensus of $11.18 billion, leading to an over 8% drop in its stock and exacerbating the overall decline in the Nasdaq 100 index, heightening market panic.
- Weak Labor Market Signals: Challenger's report shows January job cuts surged 117.8% year-on-year to 108,435, marking the highest level since 2009, indicating fragility in the US labor market and increasing investor concerns about economic outlook.
- Bitcoin Price Crash: Bitcoin (^BTCUSD) is down more than 7% today, hitting a 1.25-year low and falling about 45% from its October record high, reflecting negative sentiment in the cryptocurrency market and a trend of capital outflows.
- Impact of Earnings Season: Despite 150 S&P 500 companies set to report earnings this week and 81% of the 237 companies that have reported exceeding expectations, market concerns over future economic data continue to suppress stock performance, with S&P earnings growth expected to reach 8.4% in Q4.
See More
U.S. Stocks Extend Losses, Led by Technology Sector Declines
- Technology Sector Decline: Qualcomm (QCOM) forecasts Q2 revenue between $10.2 billion and $11.0 billion, below the consensus of $11.18 billion, leading to a more than 9% drop in its stock and triggering a sell-off across the chip sector, exacerbating market anxiety.
- Weak Labor Market Signals: Challenger reports a staggering 117.8% year-over-year increase in job cuts for January, totaling 108,435, the highest since 2009, while initial jobless claims rose by 22,000 to 231,000, indicating a weakening labor market that could impact consumer confidence and spending.
- Fed Policy Implications: Fed Governor Lisa Cook supports the decision to hold interest rates steady, emphasizing the need to maintain credibility after nearly five years of above-target inflation, which may influence future monetary policy directions.
- Bitcoin Market Turmoil: Bitcoin (^BTCUSD) is down over 3% today, hitting a 1.25-year low and falling approximately 45% from its October record high, with about $5 billion pulled from Bitcoin ETFs over the past three months, reflecting waning market confidence in cryptocurrencies.
See More
Analysis of IQV's 52-Week High and Low Points
- Price Range Analysis: IQV's 52-week low is $134.645 and high is $247.045, with the last trade at $185.35, indicating significant price volatility over the past year, reflecting varying market expectations regarding its future performance.
- Technical Analysis Insight: According to data from TechnicalAnalysisChannel.com, IQV's stock price has fallen below its 200-day moving average, which may suggest increased selling pressure in the short term, prompting investors to monitor subsequent market reactions to assess potential risks.
- Market Sentiment Impact: The current price of $185.35, compared to the 52-week high of $247.045, indicates a weakening market confidence in IQV, which could affect investor buying decisions and the company's future financing capabilities.
- Investor Focus: As IQV's stock price approaches its 52-week low, investors may reassess their investment strategies, particularly in the context of increasing market volatility, necessitating close attention to the company's fundamentals and industry dynamics.
See More
IQVIA Reports Strong Q4 but Lowers Full-Year Outlook
- Earnings Performance: IQVIA reported adjusted EPS of $3.42 and revenue of $4.4 billion for Q4 2025, exceeding market expectations by $0.02 and $120 million, respectively, reflecting approximately 10% year-over-year growth; however, shares fell, indicating market concerns about future guidance.
- Segment Growth: The Research & Development Solutions segment contributed $2.3 billion to revenue, while Technology & Analytics Solutions generated $1.8 billion, both showing around 10% year-over-year growth, underscoring the company's robust performance in its core business areas.
- Financial Outlook: Despite a strong 2025, IQVIA projected adjusted EPS of $12.55 to $12.85 for 2026 on revenue of $17.15 billion to $17.35 billion, which is below the consensus estimates of $12.96 and $17.08 billion, reflecting cautious market sentiment regarding future growth.
- Strategic Positioning: CEO Ari Bousbib emphasized that IQVIA's expanded go-to-market strategy, operational discipline, and investments in AI innovations have led to strong growth in both commercial and clinical businesses, positioning the company well for 2026 and beyond.
See More
